You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
814 Enhancing anti-tumor response in ICI-refractory non-small cell lung cancer through intravenous administration of oncolytic adenovirus armed with hTNFα and hIL-2 in combination with aPD-1 blockade

 

Online download statistics by month:

Online download statistics by month: November 2023 to July 2025

AbstractFullPdf
Nov 2023172010
Dec 20235608
Jan 20243103
Feb 20243802
Mar 20242004
Apr 20243001
May 20241602
Jun 20241401
Jul 2024801
Aug 20241203
Sep 20242601
Oct 20241207
Nov 20241604
Dec 2024405
Jan 20251607
Feb 2025407
Mar 2025002
Apr 2025103
May 2025004
Jun 2025003
Jul 2025002
Total476080